CIII nasal spray for adults living with major depressive disorder who have had an inadequate response to at least two oral ...
Because it is still awaiting approval, Medicare does not typically cover the use of ketamine infusion for treating mental ...
Researchers delivered a dose of the “love hormone” oxytocin via a nasal spray to participants and found that it decreased ...
The FDA approved Spravato for those battling depression and has seen little to no improvement from two types of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback